Event ·Multi-source

OpenAI 收购 Orchestra Bio，加码生命科学领域

OpenAI 宣布收购 Orchestra Bio，该平台帮助生物制药团队协调药物开发的复杂流程。收购后将与 Rosalind（OpenAI 面向生命科学研究的 AI 模型与工具）结合，优化药物研发运营。OpenAI 未披露本次交易金额。

Current read

OpenAI 把 Orchestra Bio 收进来了，打算和它的 Rosalind 生命科学工具打通，帮药企加快新药上市流程。

11 sources74° AI heatLast updated 2026/10/20 18:10:16

Evidence

11 sources

Primary sourceOpenAI

2026/10/20 18:10:16View source

Related source 1TestingCatalog

2026/10/20 18:21:43View source

Related source 2rohanpaul_ai

2026/10/20 18:58:27View source

Related source 3Mark Chen (OpenAI 研究)

2026/10/20 19:33:08View source

Related source 4techcrunch

2026/10/20 20:35:10View source

Related source 5kimmonismus

2026/10/20 21:21:35View source

Related source 6IT之家

2026/10/20 22:51:11View source

Related source 7Decoder

2026/10/21 08:32:54View source

Related source 8Tech in Asia

2026/10/21 06:21:20View source

Related source 9Latent.Space

2026/10/19 15:03:00View source

Related source 10Tanishq Abraham (论文推介)

2026/10/21 04:28:16View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story